Intelligence · Clinical Development
Pipeline search results
Programs matching “oncology” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 189 pipeline programs matching "oncology" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Onvansertib
Cardiff Oncology
Metastatic Castration-Resistant Prostate Cancer
1 trial -
Onvansertib
Cardiff Oncology
Colorectal Cancer
1 trial -
Onvansertib
Cardiff Oncology
Breast Cancer
1 trial -
Onvansertib
Cardiff Oncology
Acute Myeloid Leukemia
1 trial -
Onvansertib
Cardiff Oncology
Metastatic Colorectal Cancer
2 trials -
Onvansertib
Cardiff Oncology
Pancreatic Cancer
1 trial -
Onvansertib
Cardiff Oncology
Pancreatic Ductal Adenocarcinoma
1 trial -
Onvansertib
Cardiff Oncology
Small-cell Lung Cancer
1 trial -
PTR-01
BridgeBio Oncology Therapeutics
Recessive Dystrophic Epidermolysis Bullosa
1 trial -
PYX-201
Pyxis Oncology
Advanced Solid Tumors
1 trial -
PYX-201-102
Pyxis Oncology
Advanced Solid Tumors
1 trial -
Paclitaxel
Cardiff Oncology
Carcinosarcoma
1 trial -
Pantoprazole 40mg
Zealand Pharma A/S
Oncology
1 trial -
Pembrolizumab
ALX ONCOLOGY HOLDINGS INC
Ovarian Cancer
1 trial -
Placebo
Cardiff Oncology
Metastatic Breast Cancer
1 trial -
Placebo
Cardiff Oncology
Tuberous Sclerosis
1 trial -
Plerixafor
Cardiff Oncology
Acute Myeloid Leukaemia
1 trial -
Ponatinib
Cardiff Oncology
Acute Lymphoblastic Leukemia, Adult
1 trial -
Pro insulin peptide
Cardiff Oncology
Type 1 Diabetes
1 trial -
SPON - 1751-19
Cardiff Oncology
Blood cancer
1 trial -
SRF388
Coherus Oncology
Hepatocellular Carcinoma
1 trial -
STC-15 in combination with toripalimab
Coherus Oncology
Solid Tumor
1 trial -
Tipifarnib
Kura Oncology
Leukemia, Myelomonocytic, Chronic
1 trial -
Tipifarnib
Kura Oncology
HRAS Gene Mutation
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.